UCSF Navigation Bar

UCSF Departments of Pathology & Laboratory Medicine Home Page

Lab Manual for UCSF Clinical Laboratories

Lab Manual for SFGH

Internal Resources

Click here for more information about laboratory operations and procedures

If you have additional questions regarding this test, please call: 415-353-1667

Search Our Test Menu

Beta-2-glycoprotein Antibody, IgG

Item Value
Clinical Questions Does my patient have antiphospholipid syndrome (APLS)?
Available Stat? No
Test code B2GPG
Test group Beta-2-glycoprotein
Performed by Immunology
In House Availability Thursday (day shift)
Method Chemiluminescent Immunoassay
Container type Gold top preferred, Red top acceptable
Amount to Collect 3 mL blood
Sample type Serum
Preferred volume 1 mL serum
Min. Volume 0.5 mL serum
UCSF Rejection Criteria Lipemia or gross hemolysis.
Processing notes If Beta-2-Glycoprotein Antibodies are ordered without further specification, order both Beta -2-Glycoprotein Antibodies IgG and IgM (B2GPG and B2GPM).

Freeze serum at -20C.
Units CU
Normal range < 20.1 CU
Turn around times Turn around time 2-8 days
Additional information If Beta-2-Glycoprotein Antibodies are ordered without further specification, only Beta -2-Glycoprotein Antibodies IgG and IgM (B2GG and B2GM) will be done.

Antiphospholipid antibodies (APA) are associated with an increased risk of venous and arterial thrombosis and recurrent fetal loss.These antibodies can be IgG, IgM, or IgA.

Antiphospholipid antibodies require several different tests for detection. Lupus anticoagulants are detected by clotting methods. APA such as anticardiolipin antibody and anti-beta 2 glycoprotein 1 antibodies are detected by immunologic assays. Anti-Beta 2 Glycoprotein Antibodies are a more specific marker for increased risk of thrombosis than anticardiolipin assays. APA associated with thrombotic risk are persistent, and should be confirmed by a repeat positive test after 2-3 months. APA results aid in diagnosis and are helpful in determining the intensity and duration of anticoagulant treatment for patients with Antiphospholipid Syndrome and thrombosis.
CPT coding 86146
Last Updated 2/22/2017 10:30:17 PM
Entry Number 1044
UCSF home page UCSF home page About UCSF Search UCSF UCSF Medical Center